2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

Committee of Clinical Practice Guidelines, Korean Diabetes Association

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.

Original languageEnglish
Pages (from-to)398-406
Number of pages9
JournalDiabetes and Metabolism Journal
Volume43
Issue number4
DOIs
Publication statusPublished - 2019 Aug 1

Keywords

  • Diabetes mellitus, type 2
  • Diagnosis
  • Practice guideline
  • Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of '2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea'. Together they form a unique fingerprint.

  • Cite this

    Committee of Clinical Practice Guidelines, & Korean Diabetes Association (2019). 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes and Metabolism Journal, 43(4), 398-406. https://doi.org/10.4093/dmj.2019.0137